Establishment of synthetic microbial consortia with Corynebacterium glutamicum and Pseudomonas putida : Design, construction, and application to production of γ‐glutamylisopropylamide and l ‐theanine
Microbial Biotechnology · 2024-01 · 17 (1)
DOI: 10.1111/1751-7915.14400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Biotechnology, online erschienen am 11.01.2024. Verfasst von Leonie Benninghaus und 3 weiteren Autor:innen. Beteiligte Einrichtung: Genetics of Prokaryotes, Faculty of Biology and CeBiTec, Bielefeld University, Bielefeld, Germany. Hauptthemen laut MEDLINE: Corynebacterium glutamicum, Pseudomonas putida, Glutamates. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Microbial synthetic consortia are a promising alternative to classical monoculture for biotechnological applications and fermentative processes. Their versatile use offers advantages in the degradation of complex substrates, the allocation of the metabolic burden between individual partners, or the division of labour in energy utilisation, substrate supply or product formation. Here, stable synthetic consortia between the two industrially relevant production hosts, Pseudomonas putida KT2440 and Corynebacterium glutamicum ATCC13032, were established for the first time. By applying arginine auxotrophy/overproduction and/or formamidase‐based utilisation of the rare nitrogen source formamide, different types of interaction were realised, such as commensal relationships (+/0 and 0/+) and mutualistic cross‐feeding (+/+). These consortia did not only show stable growth but could also be used for fermentative production of the γ‐glutamylated amines theanine and γ‐glutamyl‐isopropylamide (GIPA). The consortia produced up to 2.8 g L −1 of GIPA and up to 2.6 g L −1 of theanine, a taste‐enhancing constituent of green tea leaves. Thus, the advantageous approach of using synthetic microbial consortia for fermentative production of value‐added compounds was successfully demonstrated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Genetics of Prokaryotes, Faculty of Biology and CeBiTec, Bielefeld University, Bielefeld, Germany.
ORCID-Profile: Leonie Benninghaus, Lynn S Schwardmann, Tatjana Jilg, Volker F Wendisch
Zitieren
APA
Benninghaus, L., Schwardmann, L. S., Jilg, T., & Wendisch, V. F. (2024). Establishment of synthetic microbial consortia with Corynebacterium glutamicum and Pseudomonas putida : Design, construction, and application to production of γ‐glutamylisopropylamide and l ‐theanine. Microbial Biotechnology, 17(1). https://doi.org/10.1111/1751-7915.14400
Vancouver
Benninghaus L, Schwardmann LS, Jilg T, Wendisch VF. Establishment of synthetic microbial consortia with Corynebacterium glutamicum and Pseudomonas putida : Design, construction, and application to production of γ‐glutamylisopropylamide and l ‐theanine. Microbial Biotechnology. 2024;17(1). doi:10.1111/1751-7915.14400
BibTeX
@article{Benninghaus2024,
author = {Benninghaus, Leonie and Schwardmann, Lynn S and Jilg, Tatjana and Wendisch, Volker F},
title = {Establishment of synthetic microbial consortia with Corynebacterium glutamicum and Pseudomonas putida : Design, construction, and application to production of γ‐glutamylisopropylamide and l ‐theanine},
journal = {Microbial Biotechnology},
year = {2024},
volume = {17},
number = {1},
doi = {10.1111/1751-7915.14400}
}
EUVIMED